These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 7883578

  • 1. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
    Banu N, Hara H, Egusa G, Yamakido M.
    Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
    [Abstract] [Full Text] [Related]

  • 2. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T, Inoguchi T, Umeda F, Nawata H, Kawano K, Ochi H.
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [Abstract] [Full Text] [Related]

  • 3. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR.
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [Abstract] [Full Text] [Related]

  • 4. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF, Mora C, Gómez M, Muros M, López-Aguilar C, García J.
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [Abstract] [Full Text] [Related]

  • 5. Urinary type IV collagen levels in diabetes mellitus.
    Sthaneshwar P, Chan SP.
    Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
    [Abstract] [Full Text] [Related]

  • 6. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O, Perna AF, Mancini FP, Iovine C, Cuomo V, Sacco M, Tufano A, Rivellese AA, Ingrosso D, Riccardi G.
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [Abstract] [Full Text] [Related]

  • 7. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y, Goto T, Tamasawa N, Matsui J, Tando Y, Sugimoto K, Tomotsune K, Kimura M, Yasujima M, Suda T.
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [Abstract] [Full Text] [Related]

  • 8. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus.
    Ozmen B, Ozmen D, Turgan N, Habif S, Mutaf I, Bayindir O.
    Ann Clin Lab Sci; 2002 Feb; 32(3):279-86. PubMed ID: 12175091
    [Abstract] [Full Text] [Related]

  • 9. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes.
    Hayashi Y, Makino H, Ota Z.
    Diabet Med; 1992 May; 9(4):366-70. PubMed ID: 1600709
    [Abstract] [Full Text] [Related]

  • 10. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V.
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [Abstract] [Full Text] [Related]

  • 11. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM, Saleh SA, Abu Shaqra QM, Hilow H.
    J Diabetes Complications; 2008 Aug; 22(6):384-8. PubMed ID: 18413152
    [Abstract] [Full Text] [Related]

  • 12. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
    Banu N, Hara H, Okamura M, Egusa G, Yamakido M.
    Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
    [Abstract] [Full Text] [Related]

  • 13. Urinary type IV collagen: a specific indicator of incipient diabetic nephropathy.
    Tan Y, Yang Y, Zhang Z, Zhang X, Zhang Z, Liu Y.
    Chin Med J (Engl); 2002 Mar; 115(3):389-94. PubMed ID: 11940372
    [Abstract] [Full Text] [Related]

  • 14. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
    Takebayashi K, Matsumoto S, Aso Y, Inukai T.
    J Diabetes Complications; 2006 Mar; 20(2):98-104. PubMed ID: 16504838
    [Abstract] [Full Text] [Related]

  • 15. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure.
    ter Meulen CG, Bilo HJ, van Kamp GJ, Gans RO, Donker AJ.
    Neth J Med; 1994 Jan; 44(1):12-7. PubMed ID: 8202200
    [Abstract] [Full Text] [Related]

  • 16. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
    Cha DR, Kim IS, Kang YS, Han SY, Han KH, Shin C, Ji YH, Kim NH.
    Diabet Med; 2005 Jan; 22(1):14-20. PubMed ID: 15606685
    [Abstract] [Full Text] [Related]

  • 17. [Urinary glycosaminoglycans in patients with non-insulin-dependent diabetes mellitus, collagen diseases and IgA nephropathy].
    Ueta I, Takamatsu K, Hashimoto K.
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):138-45. PubMed ID: 8139146
    [Abstract] [Full Text] [Related]

  • 18. Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes.
    Morita M, Uchigata Y, Hanai K, Ogawa Y, Iwamoto Y.
    Am J Kidney Dis; 2011 Dec; 58(6):915-20. PubMed ID: 21763044
    [Abstract] [Full Text] [Related]

  • 19. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
    Navarro JF, Mora C, Muros M, García J.
    Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
    [Abstract] [Full Text] [Related]

  • 20. Serum or urinary concentration of type IV collagen in diabetics.
    Watanabe T, Negishi K, Katayama S, Ishii J, Kawazu S.
    J Diabet Complications; 1991 Dec; 5(2-3):191-2. PubMed ID: 1770043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.